FNY Partners Fund’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-229,525
Closed -$17.3M 433
2017
Q4
$17.3M Buy
229,525
+158,472
+223% +$12M 2.87% 8
2017
Q3
$5.46M Buy
71,053
+41,479
+140% +$3.13M 0.93% 24
2017
Q2
$2.21M Buy
+29,574
New +$2.1M 0.54% 32

Other funds holding NVS

FNY Partners Fund's NVS Position: Q1 2018 in Review

FNY Partners Fund sold out of Novartis (NVS) in Q1 2018, closing a stake of 229,525 shares — an estimated $17.3M sold.

FNY Partners Fund first reported a position in NVS in Q2 2017 and held it in 3 quarters. The position peaked at $17.3M in Q4 2017. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

  • FNY Partners Fund reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
  • FNY Partners Fund sold 229,525 Novartis shares in Q1 2018, an estimated $17.3M.
  • FNY Partners Fund first reported a position in Novartis in Q2 2017 and held it in 3 quarters.
  • FNY Partners Fund's Novartis position peaked at $17.3M in Q4 2017.
  • 1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.